Corcept Therapeutics (CORT) Earnings Date & Reports

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

CORT is expected to report earnings to fall 103.90% to 1 cents per share on August 05

Corcept Therapeutics CORT Stock Earnings Reports

Q2'26

Est.

$0.01

Q1'26

Missed

by $0.19

Q4'25

Missed

by $0.05

Q3'25

Beat

by $0.03

Q2'25

Beat

by $0.10

The last earnings report on April 30 showed earnings per share of -30 cents, missing the estimate of -10 cents. With 649.41K shares outstanding, the current market capitalization sits at 9.22B.

View a ticker or compare two or three

Compare

Trend Trader, Long Only: Profitability Model for Russell 2000 Stocks, 60 min, (FA)Trend Trader, Long Only: Profitability Model for Russell 2000 Stocks, 60 min, (FA)

Annualized Return+19%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CORT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement